1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NATCO PHARMA LTD.
Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816
Strong Performer, Under Radar
Download real time
840.70 -5.10 (-0.60%)
44.14% Fall from 52W High
313.6K
NSE+BSE Volume

NSE 13 Oct, 2025 1:20 PM (IST)

Watchlist

Portfolio

Alert
HC Order
Delhi HC upholds its order allowing Natco to market a generic version of Roche's Risdiplam in India See details

Natco Pharma Ltd. - NATCOPHARM - stock price prediction, stock forecast, target price, analyst ratings from 10 analysts

Natco Pharma Ltd. has a share price target of Rs 982, revenue growth forecast of -12.9%, and profit growth estimate of -34.3% for FY26, based on top 10 analyst calls.

Forecaster Screeners